Related Experiment Video
Updated: Jan 11, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
981
Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs
Meilang Xue1, Hui Wang1, Frida Campos1
1Sutton Arthritis Research Laboratory, The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
International Journal of Molecular Sciences
|November 13, 2025
Summary
Discovering new biomarkers for rheumatoid arthritis (RA) is revolutionizing early diagnosis and personalized treatment. Multi-omics and microbiome research offer powerful tools for understanding and managing this complex autoimmune disease.
Area of Science:
- Rheumatology
- Immunology
- Biomarker Discovery
Background:
- Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease with unpredictable progression, complicating early diagnosis and treatment.
- Current diagnostic and treatment strategies for RA face challenges due to disease variability.
Purpose of the Study:
- To review recent advancements in biomarker discovery for rheumatoid arthritis.
- To highlight the impact of multi-omics technologies and synovial microenvironment profiling on RA research.
- To emphasize the potential of novel biomarkers for early detection, monitoring, and personalized therapy.
Main Methods:
- Review of recent literature on biomarker discovery in rheumatoid arthritis.
- Emphasis on multi-omics technologies including genomics, transcriptomics, proteomics, and metabolomics.
- Integration of gut microbiome research and synovial microenvironment profiling.
Main Results:
- Genomics and transcriptomics have identified genetic variants and expression signatures linked to RA susceptibility, progression, and treatment response.
- Proteomics and metabolomics reveal molecular patterns associated with inflammation and joint damage in RA.
- Gut microbiota show potential as non-invasive biomarkers for RA diagnosis and immunomodulation.
- Integrated multi-omics data and synovial profiling enable comprehensive molecular portraits and spatially resolved biomarkers.
Conclusions:
- Multi-omics technologies and synovial profiling are transforming RA care.
- These innovations facilitate earlier detection, improved disease monitoring, and personalized treatment strategies for RA.
- The development of comprehensive biomarker panels promises to optimize patient outcomes in rheumatoid arthritis.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
01:20The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
470
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
470
01:23Rheumatic Heart Disease I: Introduction
415
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
415
01:21Rheumatic Heart Disease III: Medical Management
272
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
272